Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 8/2015

01-08-2015 | Erratum

Erratum to: Comparison of the acceptability and benefits of two mindfulness-based interventions in women with breast or gynecologic cancer: a pilot study

Authors: Lesley Stafford, Naomi Thomas, Elizabeth Foley, Fiona Judd, Penny Gibson, Angela Komiti, Jeremy Couper, Litza Kiropoulos

Published in: Supportive Care in Cancer | Issue 8/2015

Login to get access

Excerpt

Erratum to: Support Care Cancer (2015) 23:1063–1071 …
Metadata
Title
Erratum to: Comparison of the acceptability and benefits of two mindfulness-based interventions in women with breast or gynecologic cancer: a pilot study
Authors
Lesley Stafford
Naomi Thomas
Elizabeth Foley
Fiona Judd
Penny Gibson
Angela Komiti
Jeremy Couper
Litza Kiropoulos
Publication date
01-08-2015
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 8/2015
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-015-2785-7

Other articles of this Issue 8/2015

Supportive Care in Cancer 8/2015 Go to the issue

Original Article

Applicability and evaluation of a psychosocial intervention program for childhood cancer patients

Commentary

Efficacy of a brief nurse-led pilot psychosocial intervention for newly diagnosed Asian cancer patients

Original Article

A systematic review of patient-reported outcome instruments of dermatologic adverse events associated with targeted cancer therapies

Original Article

Aiding a reassertion of self: a qualitative study of the views and experiences of women with ovarian cancer receiving long-term nurse-led telephone follow-up

Original Article

Risk factors for piperacillin/tazobactam-resistant Gram-negative infection in hematology/oncology patients with febrile neutropenia

Original Article

Opioids have no negative effect on the survival time of patients with advanced lung cancer in an acute care hospital
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits